| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.81B | 22.54B | 22.77B | 23.59B | 24.79B | 24.66B |
| Gross Profit | 6.39B | 6.25B | 5.72B | 5.30B | 5.04B | 4.86B |
| EBITDA | 2.34B | 2.29B | 1.92B | 1.90B | 1.73B | 1.85B |
| Net Income | 1.21B | 1.15B | 895.00M | 748.00M | 602.00M | 736.00M |
Balance Sheet | ||||||
| Total Assets | 24.34B | 25.56B | 24.24B | 22.81B | 22.29B | 22.82B |
| Cash, Cash Equivalents and Short-Term Investments | 6.80B | 5.92B | 10.35B | 8.43B | 7.40B | 8.72B |
| Total Debt | 831.00M | 923.00M | 532.00M | 660.00M | 874.00M | 1.36B |
| Total Liabilities | 4.48B | 5.69B | 5.06B | 4.98B | 4.95B | 6.01B |
| Stockholders Equity | 19.86B | 19.87B | 19.18B | 17.83B | 17.34B | 16.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -415.00M | 2.42B | 1.53B | -694.00M | 369.00M |
| Operating Cash Flow | 0.00 | 359.00M | 2.97B | 1.74B | -187.00M | 725.00M |
| Investing Cash Flow | 0.00 | -6.42B | -527.00M | -201.00M | -561.00M | 245.00M |
| Financing Cash Flow | 0.00 | -590.00M | -523.00M | -518.00M | -569.00M | -563.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥160.18B | 14.15 | ― | 2.30% | 13.82% | 37.07% | |
73 Outperform | ¥33.63B | 11.50 | ― | 2.22% | 9.57% | 315.38% | |
72 Outperform | ¥27.82B | 11.78 | ― | 1.21% | 7.21% | 0.30% | |
67 Neutral | ¥161.03B | 13.77 | ― | 2.22% | 9.29% | 1.18% | |
65 Neutral | ¥32.65B | 10.11 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥14.41B | 14.80 | ― | 2.98% | 5.14% | 16.05% |